
Nanogrow Biotech
Uruguay · Biotech & life sciences · Seed

Yo-Kai Express Inc.
United States · Agri & FoodTech · Series A
Compatibility /100
52/100
High potentialWhy talk
- Complementary sectors: Biotech & life sciences × Agri & FoodTech — room for a joint offer or co-selling.
- Yo-Kai Express Inc. (Series A) is one step ahead of Nanogrow Biotech (Seed) — the freshest playbook for Nanogrow Biotech's next round.
- Nanogrow Biotech likely needs funding for the next round — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer investor introductions (inferred from public profile).
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
5.5 / 10 pts
Yo-Kai Express Inc. can help Nanogrow Biotech.
- Nanogrow Biotech likely needs funding for the next round — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer investor introductions (inferred from public profile).
- Nanogrow Biotech likely needs first paying customers — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer access to its customer base (inferred from public profile).
Market bridge
2.5 / 10 pts
Distant markets.
- Yo-Kai Express Inc. is based in United States (North America): a landing pad on another continent, both ways.
Customer potential
4.3 / 5 pts
Strong customer or channel potential.
- Yo-Kai Express Inc. has strong traction in a related sector (Agri & FoodTech): More than 250 ramen vending machines deployed (SFO, Tesla factories, Ueno station), according to Taiwan News 2025 — a proven go-to-market and customer relationships Nanogrow Biotech can learn from or tap.
Sector synergy
25.0 / 50 pts
Complementary sectors.
- Complementary sectors: Biotech & life sciences × Agri & FoodTech — room for a joint offer or co-selling.
Stage complementarity
15.0 / 25 pts
Useful peer or mentor link.
- Yo-Kai Express Inc. (Series A) is one step ahead of Nanogrow Biotech (Seed) — the freshest playbook for Nanogrow Biotech's next round.
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Peers”: Needs ↔ offers 10, Market bridge 10, Customer potential 5, Sector synergy 50, Stage complementarity 25. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 50/100 — high from 50, medium from 36.